期刊文献+

重度高血压引起的血栓性微血管病肾损害 被引量:11

下载PDF
导出
摘要 目的:探讨以重度或恶性高血压为主要表现的并经肾活检病理证实的血栓性微血管病(TMA)患者的临床病理特点。方法:回顾性分析10例重度或恶性高血压伴肾脏损害,肾活检病理表现为血栓性微血管病的患者。结果:男8例,女2例,年龄23岁~49岁。患者均存在蛋白尿,2例为大量蛋白尿。9例患者表现为镜下血尿,1例患者为肉眼血尿。肾脏肿大、肾衰竭、贫血、乳酸脱氢酶升高、血小板减少的发生率依次为100%、100%、80%、40%和30%。肾脏病变累及小叶间动脉和入球小动脉,肾小球呈缺血性改变。2例患者行肾脏替代治疗。结论:重度或恶性高血压引起的TMA病变患者,微血管性溶血性贫血、血小板减少的发生率较低,预后较好。胃肠道及神经系统症状罕见。恶性高血压引起的TMA其发病机制可能和经典溶血尿毒综合征的发病机制不同。
出处 《中国中西医结合肾病杂志》 2007年第11期662-664,共3页 Chinese Journal of Integrated Traditional and Western Nephrology
  • 相关文献

参考文献10

  • 1Gurkan E,Baslamisli F,Guvenc B,et al.Thrombotic thrombocytopenic purpura in southern Turkey:a single-center experience of 29 cases.Clin Lab Haematol,2005,27 (2):121-125.
  • 2Hollenbeck M,Kutkuhn B,Aul C,et al.Haemolytic-uraemic syndrome and thrombotic-thrombocytopenic purpura in adults:clinical findings and prognostic factors for death and end-stage renal disease.Nephrol Dial Transplant,1998,13(1):76-81.
  • 3孙彬,王笑云.血栓性微血管病的肾损害[J].中国实用内科杂志,2002,22(9):524-527. 被引量:1
  • 4Kadiri S,Olutade BO.The clinical presentation of malignant hypertension in Nigerians.J Hum Hypertens,1991,5 (4):339 -343.
  • 5Ono H,Ono Y.Nephrosclerosis and hypertension.Med Clin North Am,1997,81 (6):1273-1288.
  • 6Schieppati A,Ruggenenti P,Cornejo RP,et al.Renal function at hospital admission as a prognostic factor in adult hemolytic uremic syndrome.The Italian Registry of Haemolytic Uremic Syndrome.J Am Soc Nephrol,1992,2(11):1640-1644.
  • 7Conlon PT,Howell DN,Macik G,et al.The renal manifestations and outcome of thrombotic-thrombocytopenic purpura/hemolytic-uremic syndrome in adults.Nephrol Dial Transplant,1995,10(7):1189-1193.
  • 8Morel-Maroger L,Kanfer A,Solez K,et al.Prognostic importance of vascular lesions in acute renal failure with microangiopathic hemolytic anemia (hemolytic-uremic syndrome):clinicopathologic study in 20 adults.Kidney Int,1979,15 (5):548-558.
  • 9Egan JA,Bandarenko N,Hay SN,et al.Differentiating thrombotic microangiopathies induced by severe hypertension from anemia and thrombocytopenia seen in thrombotic thrombocytopenia purpura.J Clin Apher,2004,19(3):125-129.
  • 10Veyradier A,Obert B,Houllier A,et al.Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies:a study of 111 cases.Blood,2001,98(6):1765-1772.

二级参考文献4

  • 1[1]Kevin EC, Kaplan BS.Many cell types are Shiga toxin targets. Kidney Int,2000,57:2650
  • 2[2]Dundas S, Murphy J, Soutar RL, et al.Effectiveness of therapeutic plasma exchange in the 1996 Lanarkshire Escherichia coli O157:H7 outbreak. Lancet,1999,354:1327
  • 3[3]Kaplan BS, Meyers KE, Schulman SL.The pathogenesis and treatment of hemolytic uremic syndrome. J Am Soc Nephrol,1998,9:1126
  • 4[4]Neild GH.Hemolytic uremic syndrome /thromtic thrombocytopenic purpura: pathophysiology and treatment. Kidney Int,1998,64:s45

同被引文献60

引证文献11

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部